Axxelera
Karl-Floesser-Str. 14, Karlsruhe, Baden-Wurttemberg, 76189, Germany
Overview
Axxelera manufactures high-density peptide microarrays, facilitating epitope mapping and peptide discovery. These microarrays provide invaluable insights into RNA-peptide interactions, aiding researchers in biotechnology. The company focuses on creating efficient, cost-effective, and user-friendly solutions for scientific research.
- Total investments
- 1
- Lead investments
- 1
- Investments · 12mo
- 0
- Active investors
- 2
Sector focus
- Biotechnology
- Manufacturing
Investment portfolio
- Cloov
Led · Equity · Feb 2024
Cloov, founded by Chiara Airoldi and Olimpia Santella, launched Uplyst, a software designed to help SMEs publish and manage product listings across multiple online marketplaces. Uplyst uses artificial intelligence and generative capabilities to analyze products, create or import catalogs, and adapt titles, descriptions, and categories to each marketplace's rules. The platform integrates traditional channels such as eBay, Amazon and TikTok Shop as well as next-gen marketplaces, social commerce, AI assistants and automated buying agents. Cloov positions Uplyst as a conversational, self-managed service-as-a-software that reduces the need for configured interfaces or workflows and aims to behave like a scalable dedicated team. The company plans to use new funding to broaden marketplace integrations and add features that further automate sales management and reduce publication errors and duplicate listings. The article notes the appointment of Matteo Tritto as CTO and late co-founder to drive the technical realization of these plans.